{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:38:14Z","timestamp":1789763894013,"version":"4.0.1"},"reference-count":94,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Mitochondrial antiviral signaling (MAVS) was first discovered as an activator of NF-\u03baB and IRF3 in response to viral infection in 2005. As a key innate immune adapter that acts as an \u2018on\/off\u2019 switch in immune signaling against most RNA viruses. Upon interaction with RIG-I, MAVS aggregates to activate downstream signaling pathway. The MAVS gene, located on chromosome 20p13, encodes a 540-amino acid protein that located in the outer membrane of mitochondria. MAVS protein was ubiquitously expressed with higher levels in heart, skeletal muscle, liver, placenta and peripheral blood leukocytes. Recent studies have reported MAVS to be associated with various conditions including cancers, systemic lupus erythematosus, kidney disease, and cardiovascular disease. This article provides a comprehensive summary and description of MAVS research in cardiac disease, encompassing structure, expression, protein-protein interactions, modifications, as well as the role of MAVS in heart disease. It is aimed to establish a scientific foundation for the identification of potential therapeutic target.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1540774","type":"journal-article","created":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:21:33Z","timestamp":1739838093000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":10,"title":["Exploring the role of mitochondrial antiviral signaling protein in cardiac diseases"],"prefix":"10.3389","volume":"16","author":[{"given":"Yuying","family":"Qi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiwei","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,18]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/ni1243","article-title":"IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction","volume":"6","author":"Kawai","year":"2005","journal-title":"Nat Immunol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/nature04193","article-title":"Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus","volume":"437","author":"Meylan","year":"2005","journal-title":"Nature"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2005.08.012","article-title":"Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3","volume":"122","author":"Seth","year":"2005","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2005.08.014","article-title":"VISA is an adapter protein required for virus-triggered IFN-beta signaling","volume":"19","author":"Xu","year":"2005","journal-title":"Mol Cell"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2011.08.001","article-title":"Orchestrating the interferon antiviral response through the mitochondrial antiviral signaling (MAVS) adapter","volume":"23","author":"Belgnaoui","year":"2011","journal-title":"Curr Opin Immunol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41590-019-0556-1","article-title":"Regulation of cGAS- and RLR-mediated immunity to nucleic acids","volume":"21","author":"Ablasser","year":"2020","journal-title":"Nat Immunol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nm.3424","article-title":"Host-cell sensors for Plasmodium activate innate immunity against liver-stage infection","volume":"20","author":"Liehl","year":"2014","journal-title":"Nat Med"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.cell.2019.11.016","article-title":"Metabolic Control of Astrocyte Pathogenic Activity via cPLA2-MAVS","volume":"179","author":"Chao","year":"2019","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/art.40142","article-title":"Bone marrow-derived mesenchymal stem cells from patients with systemic lupus erythematosus have a senescence-associated secretory phenotype mediated by a mitochondrial antiviral signaling protein-interferon-beta feedback loop","volume":"69","author":"Gao","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13075-019-1905-z","article-title":"The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis","volume":"21","author":"Zhang","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.919038","article-title":"Reduced immunity regulator MAVS contributes to non-hypertrophic cardiac dysfunction by disturbing energy metabolism and mitochondrial homeostasis","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"4668","DOI":"10.1038\/s41467-023-40047-w","article-title":"MAVS signaling is required for preventing persistent chikungunya heart infection and chronic vascular tissue inflammation","volume":"14","author":"Noval","year":"2023","journal-title":"Nat Commun"},{"key":"B13","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12929-022-00840-z","article-title":"TRIM18 is a critical regulator of viral myocarditis and organ inflammation","volume":"29","author":"Fang","year":"2022","journal-title":"J Biomed science"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2017.08.008","article-title":"Spontaneous activation of a MAVS-dependent antiviral signaling pathway determines high basal interferon-beta expression in cardiac myocytes","volume":"111","author":"Rivera-Serrano","year":"2017","journal-title":"J Mol Cell Cardiol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13578-019-0308-9","article-title":"Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains","volume":"9","author":"Hu","year":"2019","journal-title":"Cell bioscience"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/rmv.v20:1","article-title":"Recognition of viral nucleic acids in innate immunity","volume":"20","author":"Yoneyama","year":"2010","journal-title":"Rev Med virology"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/ni921","article-title":"IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway","volume":"4","author":"Fitzgerald","year":"2003","journal-title":"Nat Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2010.04.018","article-title":"Peroxisomes are signaling platforms for antiviral innate immunity","volume":"141","author":"Dixit","year":"2010","journal-title":"Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1110133108","article-title":"Mitochondrial-associated endoplasmic reticulum membranes (MAM) form innate immune synapses and are targeted by hepatitis C virus","volume":"108","author":"Horner","year":"2011","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e00785","DOI":"10.7554\/eLife.00785","article-title":"MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades","volume":"2","author":"Liu","year":"2013","journal-title":"eLife"},{"key":"B21","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/j.cell.2010.11.019","article-title":"Pathogen-mediated posttranslational modifications: A re-emerging field","volume":"143","author":"Ribet","year":"2010","journal-title":"Cell"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1084\/jem.20151531","article-title":"Ubiquitin in the activation and attenuation of innate antiviral immunity","volume":"213","author":"Heaton","year":"2016","journal-title":"J Exp Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.molcel.2017.09.005","article-title":"Tetherin suppresses type I interferon signaling by targeting MAVS for NDP52-mediated selective autophagic degradation in human cells","volume":"68","author":"Jin","year":"2017","journal-title":"Mol Cell"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1080\/15548627.2017.1393590","article-title":"BST2 inhibits type I IFN (interferon) signaling by accelerating MAVS degradation through CALCOCO2-directed autophagy","volume":"14","author":"Jin","year":"2018","journal-title":"Autophagy"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.2300493","article-title":"USP13 cooperates with MARCH8 to inhibit antiviral signaling by targeting MAVS for autophagic degradation in teleost","volume":"212","author":"Wang","year":"2024","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2018100978","article-title":"RNF34 functions in immunity and selective mitophagy by targeting MAVS for autophagic degradation","volume":"38","author":"He","year":"2019","journal-title":"EMBO J"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1009300","article-title":"The PB1 protein of influenza A virus inhibits the innate immune response by targeting MAVS for NBR1-mediated selective autophagic degradation","volume":"17","author":"Zeng","year":"2021","journal-title":"PloS pathogens"},{"key":"B28","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.00321-18","article-title":"TRIM21 promotes innate immune response to RNA viral infection through lys27-linked polyubiquitination of MAVS","volume":"92","author":"Xue","year":"2018","journal-title":"J Virol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00321-18","article-title":"3beta-hydroxysteroid-Delta24 reductase dampens anti-viral innate immune responses by targeting K27 ubiquitination of MAVS and STING","volume":"97","author":"Liu","year":"2023","journal-title":"J virology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"104660","DOI":"10.1016\/j.jbc.2023.104660","article-title":"TRIM28 negatively regulates the RLR signaling pathway by targeting MAVS for degradation via K48-linked polyubiquitination","volume":"299","author":"Chen","year":"2023","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","first-page":"7910","DOI":"10.1038\/ncomms8910","article-title":"The mitochondrial ubiquitin ligase MARCH5 resolves MAVS aggregates during antiviral signalling","volume":"6","author":"Yoo","year":"2015","journal-title":"Nat Commun"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903748","article-title":"The E3 ubiquitin ligase RNF5 targets virus-induced signaling adaptor for ubiquitination and degradation","volume":"184","author":"Zhong","year":"2010","journal-title":"J Immunol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.730483","article-title":"Negative regulation of RNF90 on RNA virus-triggered antiviral immune responses targeting MAVS","volume":"12","author":"Yang","year":"2021","journal-title":"Front Immunol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5536","DOI":"10.1038\/s41467-020-19318-3","article-title":"RNF115 plays dual roles in innate antiviral responses by catalyzing distinct ubiquitination of MAVS and MITA","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","first-page":"e2122805119","DOI":"10.1073\/pnas.2122805119","article-title":"Tankyrases inhibit innate antiviral response by PARylating VISA\/MAVS and priming it for RNF146-mediated ubiquitination and degradation","volume":"119","author":"Xu","year":"2022","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/ni.1815","article-title":"PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4","volume":"10","author":"You","year":"2009","journal-title":"Nat Immunol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201445","article-title":"Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation","volume":"189","author":"Wang","year":"2012","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302632","article-title":"Smurf2 negatively modulates RIG-I-dependent antiviral response by targeting VISA\/MAVS for ubiquitination and degradation","volume":"192","author":"Pan","year":"2014","journal-title":"J Immunol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1741-7007-10-44","article-title":"MAVS ubiquitination by the E3 ligase TRIM25 and degradation by the proteasome is involved in type I interferon production after activation of the antiviral RIG-I-like receptors","volume":"10","author":"Castanier","year":"2012","journal-title":"BMC Biol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3641","article-title":"The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination","volume":"18","author":"Liu","year":"2017","journal-title":"Nat Immunol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.770600","article-title":"N4BP3 regulates RIG-I-like receptor antiviral signaling positively by targeting mitochondrial antiviral signaling protein","volume":"12","author":"Wang","year":"2021","journal-title":"Front Microbiol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1202507","article-title":"Novel function of Trim44 promotes an antiviral response by stabilizing VISA","volume":"190","author":"Yang","year":"2013","journal-title":"J Immunol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41422-018-0107-6","article-title":"Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS","volume":"29","author":"Liuyu","year":"2019","journal-title":"Cell Res"},{"key":"B44","doi-asserted-by":"publisher","first-page":"e29523","DOI":"10.1002\/jmv.29523","article-title":"SIAH1 modulates antiviral immune responses by targeting deubiquitinase USP19","volume":"96","author":"Weerawardhana","year":"2024","journal-title":"J Med virology"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010299","article-title":"MicroRNA-200c-targeted contactin 1 facilitates the replication of influenza A virus by accelerating the degradation of MAVS","volume":"18","author":"Xu","year":"2022","journal-title":"PloS pathogens"},{"key":"B46","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.molcel.2020.06.020","article-title":"Acetylation-dependent deubiquitinase OTUD3 controls MAVS activation in innate antiviral immunity","volume":"79","author":"Zhang","year":"2020","journal-title":"Mol Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1800656","article-title":"The otubain YOD1 suppresses aggregation and activation of the signaling adaptor MAVS through lys63-linked deubiquitination","volume":"202","author":"Liu","year":"2019","journal-title":"J Immunol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00187-12","article-title":"Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon","volume":"86","author":"Pythoud","year":"2012","journal-title":"J virology"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2016.121","article-title":"Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia","volume":"24","author":"Cheng","year":"2017","journal-title":"Cell Death differentiation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1038\/s41467-019-11258-x","article-title":"Phosphorylation of MAVS\/VISA by Nemo-like kinase (NLK) for degradation regulates the antiviral innate immune response","volume":"10","author":"Li","year":"2019","journal-title":"Nat Commun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1801110","article-title":"NAC1 potentiates cellular antiviral signaling by bridging MAVS and TBK1","volume":"203","author":"Xia","year":"2019","journal-title":"J Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1501889","article-title":"PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1","volume":"2","author":"Xiang","year":"2016","journal-title":"Sci advances"},{"key":"B53","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1126\/sciadv.abd0276","article-title":"PPM1G restricts innate immune signaling mediated by STING and MAVS and is hijacked by KSHV for immune evasion","volume":"6","author":"Yu","year":"2020","journal-title":"Sci Adv"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1161\/hc3401.095198","article-title":"Advances in the understanding of myocarditis","volume":"104","author":"Liu","year":"2001","journal-title":"Circulation"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.89.1.314","article-title":"Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation","volume":"89","author":"Klingel","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/16.suppl_O.150","article-title":"Interferon and thymic hormones in the therapy of human myocarditis and idiopathic dilated cardiomyopathy","author":"Miric","year":"1995","journal-title":"Eur Heart J"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-016-0986-9","article-title":"Betaferon in chronic viral cardiomyopathy (BICC) trial: Effects of interferon-beta treatment in patients with chronic viral cardiomyopathy","volume":"105","author":"Schultheiss","year":"2016","journal-title":"Clin Res cardiology: Off J German Cardiac Society"},{"key":"B58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.virol.2009.10.013","article-title":"IFN-alpha expression and antiviral effects are subtype and cell type specific in the cardiac response to viral infection","volume":"396","author":"Li","year":"2010","journal-title":"Virology"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.5.2979-2987.2005","article-title":"Basal and reovirus-induced beta interferon (IFN-beta) and IFN-beta-stimulated gene expression are cell type specific in the cardiac protective response","volume":"79","author":"Stewart","year":"2005","journal-title":"J virology"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.00631-09","article-title":"MDA5 and MAVS mediate type I interferon responses to coxsackie B virus","volume":"84","author":"Wang","year":"2010","journal-title":"J virology"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2021.704494","article-title":"CVB3-mediated mitophagy plays an important role in viral replication via abrogation of interferon pathways","volume":"11","author":"Oh","year":"2021","journal-title":"Front Cell infection Microbiol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02479","article-title":"TRIM21 restricts coxsackievirus B3 replication, cardiac and pancreatic injury via interacting with MAVS and positively regulating IRF3-mediated type-I interferon production","volume":"9","author":"Liu","year":"2018","journal-title":"Front Immunol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.01590-20","article-title":"Encephalomyocarditis virus abrogates the interferon beta signaling pathway via its structural protein VP2","volume":"95","author":"Han","year":"2021","journal-title":"J Virol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1038\/s41467-024-48524-6","article-title":"ADAM9 promotes type I interferon-mediated innate immunity during encephalomyocarditis virus infection","volume":"15","author":"Bazzone","year":"2024","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-023-10377-4","article-title":"Ischemic cardiomyopathy: epidemiology, pathophysiology, outcomes, and therapeutic options","volume":"29","author":"Pastena","year":"2024","journal-title":"Heart failure Rev"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2215025","article-title":"Cardiovascular safety of testosterone-replacement therapy","volume":"389","author":"Lincoff","year":"2023","journal-title":"New Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.02.054","article-title":"The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation","volume":"153","author":"Subramanian","year":"2013","journal-title":"Cell"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvt091","article-title":"The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury","volume":"99","author":"Sandanger","year":"2013","journal-title":"Cardiovasc Res"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw247","article-title":"The selective NLRP3-inflammasome inhibitor MCC950 reduces infarct size and preserves cardiac function in a pig model of myocardial infarction","volume":"38","author":"van Hout","year":"2017","journal-title":"Eur Heart J"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.scib.2021.01.030","article-title":"TAX1BP1 protects against myocardial infarction-associated cardiac anomalies through inhibition of inflammasomes in a RNF34\/MAVS\/NLRP3-dependent manner","volume":"66","author":"Xu","year":"2021","journal-title":"Sci bulletin"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2016.06.013","article-title":"NLRX1 attenuates apoptosis and inflammatory responses in myocardial ischemia by inhibiting MAVS-dependent NLRP3 inflammasome activation","volume":"76","author":"Li","year":"2016","journal-title":"Mol Immunol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41421-023-00622-3","article-title":"The E3 ubiquitin ligase MARCH2 protects against myocardial ischemia-reperfusion injury through inhibiting pyroptosis via negative regulation of PGAM5\/MAVS\/NLRP3 axis","volume":"10","author":"Liu","year":"2024","journal-title":"Cell discovery"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.02.043","article-title":"Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse","volume":"209","author":"Toldo","year":"2016","journal-title":"Int J Cardiol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"108053","DOI":"10.1016\/j.pharmthera.2021.108053","article-title":"Targeting the NLRP3 inflammasome in cardiovascular diseases","volume":"236","author":"Toldo","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.18632\/aging.203435","article-title":"NLRP3 inflammasome activation contributes to the pathogenesis of cardiocytes aging","volume":"13","author":"Liao","year":"2021","journal-title":"Aging"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-018-1691-0","article-title":"NLRP3 deficiency accelerates pressure overload-induced cardiac remodeling via increased TLR4 expression","volume":"96","author":"Li","year":"2018","journal-title":"J Mol Med"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1038\/labinvest.2013.99","article-title":"NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload","volume":"93","author":"Zong","year":"2013","journal-title":"Lab investigation; J Tech Methods pathology"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.041213","article-title":"Innate immune nod1\/RIP2 signaling is essential for cardiac hypertrophy but requires mitochondrial antiviral signaling protein for signal transductions and energy balance","volume":"142","author":"Lin","year":"2020","journal-title":"Circulation"},{"key":"B79","doi-asserted-by":"publisher","first-page":"5343","DOI":"10.1038\/s41467-023-41028-9","article-title":"MAVS integrates glucose metabolism and RIG-I-like receptor signaling","volume":"14","author":"He","year":"2023","journal-title":"Nat Commun"},{"key":"B80","doi-asserted-by":"publisher","first-page":"2167129","DOI":"10.1155\/2020\/2167129","article-title":"The reduced oligomerization of MAVS mediated by ROS enhances the cellular radioresistance","volume":"2020","author":"Du","year":"2020","journal-title":"Oxid Med Cell longevity"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1108586108","article-title":"The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse","volume":"108","author":"Mezzaroma","year":"2011","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B83","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00395-014-0415-z","article-title":"TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia\/reperfusion injury","volume":"109","author":"Liu","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701569","article-title":"TRIM29 negatively regulates the type I IFN production in response to RNA virus","volume":"201","author":"Xing","year":"2018","journal-title":"J Immunol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3580","article-title":"Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract","volume":"17","author":"Xing","year":"2016","journal-title":"Nat Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1038\/s41467-024-44745-x","article-title":"Loss of TRIM29 mitigates viral myocarditis by attenuating PERK-driven ER stress response in male mice","volume":"15","author":"Wang","year":"2024","journal-title":"Nat Commun"},{"key":"B87","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00395-020-0781-7","article-title":"M1-like macrophage-derived exosomes suppress angiogenesis and exacerbate cardiac dysfunction in a myocardial infarction microenvironment","volume":"115","author":"Liu","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.2015.19.issue-12","article-title":"Up-regulated TLR4 in cardiomyocytes exacerbates heart failure after long-term myocardial infarction","volume":"19","author":"Liu","year":"2015","journal-title":"J Cell Mol Med"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000043825.01705.1b","article-title":"Neutrophils orchestrate post-myocardial infarction healing by polarizing macrophages towards a reparative phenotype","volume":"38","author":"Horckmans","year":"2017","journal-title":"Eur Heart J"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000043825.01705.1B","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ Res"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20070885","article-title":"The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions","volume":"204","author":"Nahrendorf","year":"2007","journal-title":"J Exp Med"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1053171","article-title":"TRIM21 aggravates cardiac injury after myocardial infarction by promoting M1 macrophage polarization","volume":"13","author":"Li","year":"2022","journal-title":"Front Immunol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1038\/s41385-019-0190-0","article-title":"Neutrophil recruitment and activation are differentially dependent on MyD88\/TRIF and MAVS signaling during RSV infection","volume":"12","author":"Kirsebom","year":"2019","journal-title":"Mucosal Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02097-16","article-title":"MAVS Is Essential for Primary CD4(+) T Cell Immunity but Not for Recall T Cell Responses following an Attenuated West Nile Virus Infection","volume":"91","author":"Luo","year":"2017","journal-title":"J virology"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1540774\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:21:37Z","timestamp":1739838097000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1540774\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,18]]},"references-count":94,"alternative-id":["10.3389\/fimmu.2025.1540774"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1540774","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,18]]},"article-number":"1540774"}}